HOME STORY OF OUR FIRM SEARCH
ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
No
Were you diagnosed with lung cancer? Yes
No
Were you diagnosed with Mesothelioma? yes
no
What is your date of diagnosis?
Additional Comments
Best time to call?

Clinical Trials for Mesothelioma Patients: Immunotoxin Therapy Contact Information

Read more here to obtain contact information for the facilities participating in the current clinical trial being conducted to study the effects of Immunotoxin Therapy treatment for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

Locations:
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Bethesda, Maryland, United States, 20892-1182
Contact: Clinical Trials Office
888-NCI-1937

Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney
Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


IN THIS SECTION
Immunotoxin therapy for mesothelioma patients
Objectives of Immunotoxin trial on mesothelioma
Study outline for Immunotoxin mesothelioma trial
Disease traits in Immunotoxin mesothelioma trial
Patient traits: Immunotoxin mesothelioma trial
Contact info for Immunotoxin mesothelioma program

RETURN BACK TO
Mesothelioma
Treatment of Mesothelioma
Treatment
Clinical trials on asbestos illness: mesothelioma

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING
see also:

Immunotoxin therapy for mesothelioma patients Therapy program to treat mesothelioma patients with Immunotoxin
Outcome measures for Immunotoxin therapy test on mesothelioma patients

Objectives of Immunotoxin trial on mesothelioma Study objectives for program to treat mesothelioma with Immunotoxin
Primary objectives of Immunotoxin clinical trial against mesothelioma

Current Immunotoxin therapy: mesothelioma patients Current clinical trial of Immunotoxin therapy: mesothelioma patients
Immunotoxin may inhibit cancer cell growth in mesothelioma test